- a relating to or involving or causing hemolysis
News & Articles
- Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease
On 11th December the National Institute for Health and Care Excellence's (NICE) First Appraisal meeting is taking place to judge whether eculizumab should be recommended in England as a treatment for the ultra-rare disease atypical Haemolytic Uraemic Syndrome (aHUS). National commissioning of this drug for the treatment of aHUS was recommended in June 2012 by the Advisory Group for National ...
Dec. 5, 2013 - PR Newswire via Yahoo! Finance